#obesitydrugs — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #obesitydrugs, aggregated by home.social.
-
https://www.europesays.com/dk/80383/ Novo Nordisk Unveils Fresh Wegovy Data That Could Narrow Eli Lilly’s Obesity Lead #EliLilly #GLP1WeightLossDrugs #LlyStock #NovoNordisk #NVOStock #ObesityDrugs #Semaglutide72Mg #Wegovy®HD #zepbound
-
https://www.europesays.com/dk/76609/ Novo sees comeback as weight-loss pill boom revives investor confidence – Firstpost #DenmarkPharma #EliLilly #Foundayo #GLP1Drugs #HealthcareStocks #NovoNordisk #NovoShares #ObesityDrugs #ObesityTreatmentMarket #ozempic #PeptideTherapies #PharmaNews #WegovyPill #WeightLossDrugCompetition #WeightLossPill
-
https://www.europesays.com/dk/?p=76118 Novo Nordisk’s Weight-Loss Pill Fuels Strategic Rebound #EliLilly #investors #NewDrugLaunch #NovoNordisk #ObesityDrugs #PharmaceuticalSector #SalesStrategy #USMarket #Wegovy #WeightLossPill
-
https://www.europesays.com/dk/75598/ Novo Nordisk Share Price: Obesity Pill Ka Craze Hai, Par Profitability Ki Testing Shuru! #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket
-
https://www.europesays.com/dk/75448/ Novo Nordisk’s Obesity Pill Demand Soars, Profitability Faces Tough Test #DrugPricing #EliLilly #Foundayo #HealthcareCompetition #MarketShare #NovoNordisk #ObesityDrugs #Pharmaceuticals #PriceWar #Q1Earnings #Wegovy #WeightLossMarket
-
https://www.europesays.com/dk/?p=74979 Novo Nordisk’s Weight-Loss Pill Fuels Fierce Rivalry with Eli Lilly #EliLilly #MarketShare #NovoNordisk #ObesityDrugs #ObesityTreatment #PharmaceuticalCompetition #PrescriptionGrowth #PricePressures #Wegovy #WeightLossPill
-
Patients on this drug are burdened by cost. How CT wants to bring prices down
After Bonnie had part of her thyroid removed, weight gain accompanied the aftermath of the procedure. The Connecticut…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #Connecticutnews #ctnews #drugcosts #GLP-1 #hartfordcourant #Health #localnews #MaxImagePreview #obesitydrugs #Prescriptiondrugs #Sen.JeffGordon #Sen.MattLesser #weightloss
https://www.newsbeep.com/us/464551/ -
Patients on this drug are burdened by cost. How CT wants to bring prices down
After Bonnie had part of her thyroid removed, weight gain accompanied the aftermath of the procedure. The Connecticut…
#NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Healthcare #Connecticutnews #ctnews #drugcosts #GLP-1 #hartfordcourant #Health #localnews #MaxImagePreview #obesitydrugs #Prescriptiondrugs #Sen.JeffGordon #Sen.MattLesser #weightloss
https://www.newsbeep.com/us/464551/ -
Hims & Hers Health adds popular obesity drugs to platform, including Zepbound and Mounjaro, driving 5% stock increase amid expanding weight loss market
#YonhapInfomax #HimsAndHersHealth #ObesityDrugs #Zepbound #Mounjaro #WeightLossTreatments #Economics #FinancialMarkets #Banking #Securities #Bonds #StockMarket
https://en.infomaxai.com/news/articleView.html?idxno=56748 -
"Corporate affairs professionals say #food companies are overwhelmed by the level of public concern about #UPF and are scrambling to find an effective way to counter it."
"Two-thirds of Europeans now believe that #UltraProcessedFood are unhealthy and will cause #health problems in later life (...) and do not trust that the authorities are regulating them well enough."#FoodIndustry #diet #JunkFood #HealthyDiet #PublicHealth #policy #obesity #ObesityDrugs #BigPharma #ResearchIntegrity #MustRead
-
Deny, denounce, delay: the battle over the risk of #UltraProcessedFood
Despite a growing body of evidence, #BigFood is trying to dampen fears about the #health effects of industrially formulated substances using the tools and tricks of the #TobaccoIndustry: https://archive.ph/od3sw
(Edit: updated link.)
#FoodIndustry #UPF #Nova #CarlosMonteiro #diet #JunkFood #food #HealthyDiet #PublicHealth #policy #ResearchIntegrity #obesity #ObesityDrugs #BigPharma #BigTobacco #FinancialTimes #FT #MustRead